Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994

By Stamey T.A.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 173-184

Elsevier

Access to resources Recommend Favorite

Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free:total PSA ratios in a consecutive series of men referred for prostate biopsies

By Rydén Linda   Egevad Lars   Ekman Peter   Hellström Magnus  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 302-307

Informa Healthcare

Access to resources Recommend Favorite

Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml

By Elabbady Ahmed   Khedr Mahrousa  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 553-557

Springer Publishing Company

Access to resources Recommend Favorite

Relationship of demographic and clinical factors to free and total prostate-specific antigen 1

By Gelmann E.P.   Chia D.   Pinsky P.F.   Andriole G.L.   Crawford E.D.   Reding D.   Hayes R.B.   Kramer B.S.   Woodrum D.L.   Gohagan J.K.   Levin D.L.   For the PLCO Screening Trial Investigators  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 561-566

Elsevier

Access to resources Recommend Favorite

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)

By Aus Gunnar   Becker Charlotte   Lilja Hans   Khatami Ali   Pihl Carl-Gustaf   Hugosson Jonas  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 466-470

Informa Healthcare

Access to resources Recommend Favorite